Compare Ginkgo Bioworks Holdings Inc (DNA) vs iShares Bitcoin Trust (IBIT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs iShares Bitcoin Trust — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.54 (market cap $515.15M), while iShares Bitcoin Trust trades at $36.03. The key difference: Ginkgo Bioworks Holdings Inc is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals.
| DNA | IBIT | |
|---|---|---|
Market Cap | $515.15M | — |
Sector | Health | Crypto-linked |
52-Week High | $16.14 | $71.29 |
52-Week Low | $5.48 | $33.29 |
Enterprise Value | $617.10M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $7.97, down 6.24% today, reflecting ongoing operational challenges. The company reported Q2 2026 revenue of $20 million, a 48% year-over-year decline, as it shifts focus to autonomous lab systems. Despite beating EPS expectations in two of the last three quarters, net losses remain substantial with a -219.6% margin. Technical indicators show bearish momentum with support at $7 and resistance at $9.
DNA faces significant headwinds with declining revenue and persistent losses, though analyst sentiment is mixed with 45% buy ratings. The pivot to new business lines creates uncertainty, while cash burn and competitive pressures present substantial risks. Upside depends on successful execution of the strategic shift and path to profitability.
IBIT trades at $36.80, up 0.85% today, with a bullish technical signal from moving averages and neutral oscillators. Key support is at $36 and resistance at $37. Recent news highlights strong institutional interest, with BlackRock's head of digital assets noting 'overwhelming demand' for crypto ETFs (Bloomberg, 2026-08-10).
The outlook is cautiously optimistic given technical strength and institutional inflows, but risks include Bitcoin price volatility and regulatory uncertainty. Analyst sentiment is mixed, with some recommending long-term buys amid crypto market downturns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About iShares Bitcoin Trust
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →
